Fiducial marker placement with electromagnetic navigation bronchoscopy: a subgroup analysis of the prospective, multicenter NAVIGATE study

Abstract

Background: Fiducial markers (FMs) help direct stereotactic body radiation therapy (SBRT) and localization for surgical resection in lung cancer management. We report the safety, accuracy, and practice patterns of FM placement utilizing electromagnetic navigation bronchoscopy (ENB). Methods: NAVIGATE is a global, prospective, multicenter, observational cohort study of ENB using the superDimension™ navigation system. This prospectively collected subgroup analysis presents the patient demographics, procedural characteristics, and 1-month outcomes in patients undergoing ENB-guided FM placement. Follow up through 24 months is ongoing. Results: Two-hundred fifty-eight patients from 21 centers in the United States were included. General anesthesia was used in 68.2%. Lesion location was confirmed by radial endobronchial ultrasound in 34.5% of procedures. The median ENB procedure time was 31.0 min. Concurrent lung lesion biopsy was conducted in 82.6% (213/258) of patients. A mean of 2.2 ± 1.7 FMs (median 1.0 FMs) were placed per patient and 99.2% were accurately positioned based on subjective operator assessment. Follow-up imaging showed that 94.1% (239/254) of markers remained in place. The procedure-related pneumothorax rate was 5.4% (14/258) overall and 3.1% (8/258) grade ⩾ 2 based on the Common Terminology Criteria for Adverse Events scale. The procedure-related grade ⩾ 4 respiratory failure rate was 1.6% (4/258). There were no bronchopulmonary hemorrhages. Conclusion: ENB is an accurate and versatile tool to place FMs for SBRT and localization for surgical resection with low complication rates. The ability to perform a biopsy safely in the same procedure can also increase efficiency. The impact of practice pattern variations on therapeutic effectiveness requires further study. Trial registration: ClinicalTrials.gov identifier: NCT02410837.

Pleural dye marking of lung nodules by electromagnetic navigation bronchoscopy

“…NAVIGATE (http://www.clinicaltrials.gov, NCT02410837) is a prospective, multicentre, global, and single‐arm cohort study evaluating ENB procedures . All ENB procedures used the superDimension navigation system version 6.0 or higher (Medtronic, Minneapolis, MN).…”

“…The objective of this subgroup analysis is to evaluate the ENB‐guided dye marking usage patterns, techniques and performance in a multicentre experience. Results of ENB‐guided fiducial marking in NAVIGATE have been previously published …”

Navigational Bronchoscopy with Interventional Pulmonologists and Thoracic Surgeons

“…As previously reported in the literature, these systems are useful and have good results in terms of feasibility and safety, with low fiducial migration rates. 16 -18…”

Papel da broncologia no cancro do pulmão: (R)evolução nos últimos 20 anos

“…A localização e tamanho da lesão, a existência de sinal brônquico e o tipo de biopsia/punção realizada fazem com que a sensibilidade diagnóstica seja cerca de 73% 26,27 . Alguns trabalhos demonstram, igualmente, a eficácia deste sistema na colocação correta de marcadores fiduciais para orientação de radioterapia 28 ou na localização de pequenos nódulos Papel da broncologia no cancro do pulmão: (R)evolução... sólidos ou em vidro despolido com injeção de azul de metileno/substâncias corantes que facilitam a localização e ressecção cirúrgica 29 . O perfil de segurança faz com que seja um sistema de escolha para doentes com baixa reserva pulmonar ou marcado enfisema, em que se pretende evitar a todo o custo um pneumotórax iatrogénico.…”